The NCI comprehensive centre for Kansas and western Missouri, active in drug repurposing, triple-negative breast cancer trials and rural access.
NCI-designated in 2012 and comprehensive since 2022, KU Cancer Center covers Kansas and western Missouri and reaches rural communities through the Masonic Cancer Alliance. Priyanka Sharma leads SWOG triple-negative breast cancer trials from here, and the Institute for Advancing Medical Innovation runs drug discovery and repurposing programmes. Research strengths include liquid biopsy, cancer biology and clinical trials in haematologic malignancies and breast cancer. The centre partners with Children's Mercy Kansas City for paediatric oncology.
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-15.
Matched to The University of Kansas Cancer Center, including child institutions. 365 works · 4,909 citations · 68% open access · 19% clinical trials · 1% reviews.
Shares NCI-Designated Cancer Centers, Proton therapy machines: cyclotrons, synchrotrons and single-room systems, Proton therapy, National Cancer Institute (NIH).
Shares NCI-Designated Cancer Centers, Proton therapy machines: cyclotrons, synchrotrons and single-room systems, Proton therapy, National Cancer Institute (NIH).
Shares Proton therapy machines: cyclotrons, synchrotrons and single-room systems, Proton therapy, National Cancer Institute (NIH), Multiple myeloma.
Shares NCI-Designated Cancer Centers, Proton therapy machines: cyclotrons, synchrotrons and single-room systems, Proton therapy, National Cancer Institute (NIH).
Shares NCI-Designated Cancer Centers, SWOG Cancer Research Network, National Cancer Institute (NIH).
Shares NCI-Designated Cancer Centers, Proton therapy, National Cancer Institute (NIH).
Shares Systematic drug repurposing, No incentive to repurpose cheap drugs.
Shares Trials enrol too few, too slowly, Multiple myeloma, Triple-negative breast cancer (TNBC).